Access Support for Hard-to-Find Medicines in Kenya
Bioniche Limited supports patients, caregivers, healthcare providers and hospitals with access to hard-to-find medicines that may be unavailable, out of stock or not routinely supplied in Kenya. Through our structured access model, we assist with product availability checks, prescription review, sourcing coordination and regulatory support for prescribed specialty medicines.
Our commitment is to help patients access essential therapies through a responsible, compliant and patient-focused process.
What Are Hard-to-Find Medicines?
Hard-to-find medicines are prescribed products that may not be readily available through normal distribution channels. They may be temporarily out of stock, available only through specialist suppliers, require special import arrangements or be supplied in limited quantities.
These medicines can include oncology therapies, orphan drugs, transplant medicines, immunotherapies, paediatric formulations and other specialty pharmaceuticals.
Bioniche Limited works with trusted manufacturers and supply partners to help locate and coordinate access to these medicines whenever possible.
Medicines We Support
We assist with enquiries for:
- Oncology medicines
- Orphan and rare disease medicines
- Immunotherapies
- Targeted therapies
- Renal and transplant medicines
- Paediatric formulations
- Dysphagia-friendly medicines
- Specialty pharmaceuticals
- Medicines requiring special sourcing
- Non-stock prescription medicines
If the medicine you require is not listed, our team can assess your request and advise on the most appropriate access pathway.
Our Access Services
Bioniche Limited provides support with:
- Medicine availability enquiries
- Prescription verification
- Product sourcing
- Named Patient Programme requests
- Product quotations
- Special import support where applicable
- Hospital and institutional supply
- Regulatory documentation guidance
- Delivery coordination and follow-up
Availability depends on manufacturer supply, documentation requirements and applicable regulatory approvals.